PLYMOUTH, MA, MitoSense, a biotechnology company, announced the close of its Series Seed Funding Round led by Caydan Capital Partners, raising close to $3.5 million.
MitoSense Inc., a research and development company focused on neurodegenerative disease treatments, announces the successful closure of its Series Seed Funding Round led by Caydan Capital Partners, raising close to $3.5 million.
MitoSense Inc. is a biotechnology company dedicated to advancing mitochondrial health through innovative therapies and research, focusing on treatments for neurodegenerative diseases.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
